EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Proteins Associated with COVID-19 Severity in Puerto Rico

Lester J Rosario-Rodríguez iD, Yadira M Cantres-Rosario, Kelvin Carrasquillo-Carrión iD, Alexandra Rosa-Díaz iD, Ana E Rodríguez-De Jesús, Verónica Rivera-Nieves, Eduardo L Tosado-Rodríguez iD, Loyda B Méndez iD, Abiel Roche-Lima iD, Jorge Bertrán, Loyda M Meléndez iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lester J Rosario-Rodríguez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Medical Zoology, University of Puerto Rico, Medical Sciences Campus, San Juan 00935, Puerto Rico. Hauptthemen laut MEDLINE: COVID-19, Severity of Illness Index, SARS-CoV-2, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, National Institute of Minority Health and Health Disparities (NIMHHD), NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral strains, age, and host factors are associated with variable immune responses against SARS-CoV-2 and disease severity. Puerto Ricans have a genetic mixture of races: European, African, and Native American. We hypothesized that unique host proteins/pathways are associated with COVID-19 disease severity in Puerto Rico. Following IRB approval, a total of 95 unvaccinated men and women aged 21–71 years old were recruited in Puerto Rico from 2020–2021. Plasma samples were collected from COVID-19-positive subjects (n = 39) and COVID-19-negative individuals (n = 56) during acute disease. COVID-19-positive individuals were stratified based on symptomatology as follows: mild (n = 18), moderate (n = 13), and severe (n = 8). Quantitative proteomics was performed in plasma samples using tandem mass tag (TMT) labeling. Labeled peptides were subjected to LC/MS/MS and analyzed by Proteome Discoverer (version 2.5), Limma software (version 3.41.15), and Ingenuity Pathways Analysis (IPA, version 22.0.2). Cytokines were quantified using a human cytokine array. Proteomics analyses of severely affected COVID-19-positive individuals revealed 58 differentially expressed proteins. Cadherin-13, which participates in synaptogenesis, was downregulated in severe patients and validated by ELISA. Cytokine immunoassay showed that TNF-α levels decreased with disease severity. This study uncovers potential host predictors of COVID-19 severity and new avenues for treatment in Puerto Ricans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Severity of Illness IndexSARS-CoV-2ProteomicsHumansMiddle AgedPuerto RicoFemaleMaleAdultAgedBlood ProteinsYoung AdultCytokinesTandem Mass Spectrometry

Stichwörter der Autor:innen

COVID-19H-cadherinPuerto RicoSARS-CoV-2T-cadherinTNF-αcadherin-13proteomics

Substanzen

Blood ProteinsCytokines

Autor:innen und Institutionen

  • Department of Microbiology and Medical Zoology, University of Puerto Rico, Medical Sciences Campus, San Juan 00935, Puerto Rico.
  • Translational Proteomics Center, Research Capacity Core, Center for Collaborative Research in Health Disparities, University of Puerto Rico, Medical Sciences Campus, San Juan 00935, Puerto Rico.
  • Integrated Informatics, Research Capacity Core, Center for Collaborative Research in Health Disparities, University of Puerto Rico, Medical Sciences Campus, San Juan 00935, Puerto Rico.
  • Interdisciplinary Studies, Natural Sciences, University of Puerto Rico, Río Piedras Campus, San Juan 00925, Puerto Rico.
  • Department of Science & Technology, Ana G. Mendez University, Carolina 00928, Puerto Rico.
  • Infectious Diseases, Auxilio Mutuo Hospital, San Juan 00919, Puerto Rico.

ORCID-Profile: Lester J Rosario-Rodríguez, Kelvin Carrasquillo-Carrión, Alexandra Rosa-Díaz, Eduardo L Tosado-Rodríguez, Loyda B Méndez, Abiel Roche-Lima, Loyda M Meléndez

Förderung

  • NIMHD NIH HHS
  • National Institute of Minority Health and Health Disparities (NIMHHD)
  • NINDS NIH HHS
  • CSRD VA
  • NIGMS NIH HHS
  • UPR COVID19 Emergency Funds
  • National Institutes of Health National Institute of General Medical Sciences (NIGMS) PR-INBRE-Institutional Developmental Award (IDEA)
  • Research Infrastructure Core components—National Institute of Minority Health and Health Disparities (NIMHHD)

Zitieren

APA

Rosario-Rodríguez, L. J., Cantres-Rosario, Y. M., Carrasquillo-Carrión, K., Rosa-Díaz, A., Rodríguez-De Jesús, A. E., Rivera-Nieves, V., Tosado-Rodríguez, E. L., Méndez, L. B., Roche-Lima, A., Bertrán, J., & Meléndez, L. M. (2024). Plasma Proteins Associated with COVID-19 Severity in Puerto Rico. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105426

Vancouver

Rosario-Rodríguez LJ, Cantres-Rosario YM, Carrasquillo-Carrión K, Rosa-Díaz A, Rodríguez-De Jesús AE, Rivera-Nieves V, et al. Plasma Proteins Associated with COVID-19 Severity in Puerto Rico. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105426

BibTeX
@article{RosarioRodrguez2024,
  author = {Rosario-Rodríguez, Lester J and Cantres-Rosario, Yadira M and Carrasquillo-Carrión, Kelvin and Rosa-Díaz, Alexandra and Rodríguez-De Jesús, Ana E and Rivera-Nieves, Verónica and Tosado-Rodríguez, Eduardo L and Méndez, Loyda B and Roche-Lima, Abiel and Bertrán, Jorge and Meléndez, Loyda M},
  title = {Plasma Proteins Associated with COVID-19 Severity in Puerto Rico},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105426}
}
Kostenlos starten →